News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 762 results

10x Genomics 'overjoyed' to win UPC preliminary injunction

EU19-09-2023Legal developmentsSarah Speight

Decision marks first announcement by the UPC of an injunction in open court | Ruling in Munich Local Division forecast to have far-reaching consequences for defendant| Comment from 10x vice president of IP and litigation, Randy Wu.

EPO launches Unitary Patent dashboard revealing daily take-up figures

EU25-07-2023Liz Hockley

Interactive statistics chart shows more than 5,000 requests for unitary effect | Data can be filtered by country, language and technology sector.

Compugen’s anti-PVRIG patent upheld by the EPO

EU18-07-2023Marisa Woutersen

Opposition Division ruling supports the use of immunotherapy patent | Highlights the significance of plausibility in patent evaluation following G 2/21.

UPC: Milan confirmed as third seat but Munich lands chemistry, minus SEPs

EU27-06-2023Marisa Woutersen

UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs.

UK appoints first female Lord Chief Justice in 755 years

UK22-06-2023Marisa Woutersen

Dame Sue Carr takes over from Lord Burnett of Maldon, assuming responsibilities in October.

European Commission proposes ‘single market’ for meds

EU27-04-2023Liz Hockley

Proposals include new regulatory protection periods for innovative drugs | Changes are aimed at improving patient access to therapeutics and boosting the EU pharma industry.

Cipla loses fightback over diarrhoea antibiotic

India25-04-2023Liz Hockley

Judge rejects notion that tribunal acted unfairly in royalties dispute with Salix | Indian firm wanted payments on sales of antibiotic | Appeal brought under act with ‘high hurdle to surmount’.

EPO Enlarged Board of Appeal issues G 2/21 decision

EU28-03-2023Liz Hockley

Board provides guidance on evidence submitted after patent filing date | Eagerly awaited decision confirms what’s needed to prove a certain effect.

Oxford University startup ordered to pay royalties

UK05-01-2023Staff Writer

‘Rare’ case included ‘campaigning element’ says judge | Ex-student sought clarification on royalties from university | 651-paragraph ruling required Oxford Uni to justify its IP policies.

Amgen seals $28m deal for biotech

Ireland, US13-12-2022Staff Writer

Two rivals withdrew from acquisition process| Agreement provides access to blockbuster medicines | Janssen Global Services | Sanofi.

Showing 1 to 10 of 762 results

LSIPR